Response to clozapine in treatment resistant schizophrenia is related to alterations in regional cerebral blood flow
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Response to clozapine in treatment resistant schizophrenia is related to alterations in regional cerebral blood flow ; volume:10 ; number:1 ; day:23 ; month:12 ; year:2024 ; pages:1-8 ; date:12.2024
Schizophrenia ; 10, Heft 1 (23.12.2024), 1-8, 12.2024
- Urheber
-
Sun, Junyu
Zelaya, Fernando
Sendt, Kyra-Verena
McQueen, Grant
Gillespie, Amy L.
Lally, John
Howes, Oliver D.
Barker, Gareth J.
McGuire, Philip K.
MacCabe, James H.
Egerton, Alice
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41537-024-00544-3
- URN
-
urn:nbn:de:101:1-2503032138541.383532077013
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
2025-08-15T07:30:26+0200
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sun, Junyu
- Zelaya, Fernando
- Sendt, Kyra-Verena
- McQueen, Grant
- Gillespie, Amy L.
- Lally, John
- Howes, Oliver D.
- Barker, Gareth J.
- McGuire, Philip K.
- MacCabe, James H.
- Egerton, Alice
- SpringerLink (Online service)
Ähnliche Objekte (12)
When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis
An international research agenda for clozapine-resistant schizophrenia
Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia
Application of Clozapine to aggressive patients
Slower clozapine titration is associated with delayed onset of clozapine-induced fever among Japanese patients with schizophrenia
Aripirazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia
A systematic review of neuroimaging studies of clozapine-resistant schizophrenia
Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia
Clozapine-associated Development of Second-onset Obsessive Compulsive Symptoms in Schizophrenia: Impact of Clozapine Serum Levels and Fluvoxamine Add-on
Severity in sustained attention impairment and clozapine-resistant schizophrenia: a retrospective study
N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms
Cerebral lateralization in schizophrenia and dyslexia : neuromagnetic responses to auditory stimuli
When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis
An international research agenda for clozapine-resistant schizophrenia
Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia
Application of Clozapine to aggressive patients
Slower clozapine titration is associated with delayed onset of clozapine-induced fever among Japanese patients with schizophrenia
Aripirazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia
A systematic review of neuroimaging studies of clozapine-resistant schizophrenia
Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia
Clozapine-associated Development of Second-onset Obsessive Compulsive Symptoms in Schizophrenia: Impact of Clozapine Serum Levels and Fluvoxamine Add-on
Severity in sustained attention impairment and clozapine-resistant schizophrenia: a retrospective study
N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms
Cerebral lateralization in schizophrenia and dyslexia : neuromagnetic responses to auditory stimuli
When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis
An international research agenda for clozapine-resistant schizophrenia
Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia
Application of Clozapine to aggressive patients
Slower clozapine titration is associated with delayed onset of clozapine-induced fever among Japanese patients with schizophrenia
Aripirazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia
A systematic review of neuroimaging studies of clozapine-resistant schizophrenia
Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia
Clozapine-associated Development of Second-onset Obsessive Compulsive Symptoms in Schizophrenia: Impact of Clozapine Serum Levels and Fluvoxamine Add-on
Severity in sustained attention impairment and clozapine-resistant schizophrenia: a retrospective study
N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms